Atlas Trials

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

Clinical trial NCT05241249 · RECRUITING

Trial details

NCT number
NCT05241249
Sponsor
Susan E. Bates
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreas Cancer
Start date
2022-02-01
Primary completion
2026-01-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.